Perimeter Medical Imaging, Inc., a Toronto, ON, Canada-based developer of real time imaging systems for in-surgery tissue assessment, closed a $5m Series A financing.
The round was led by Roadmap Capital with participation from EPIC Capital, NorthView Ventures and Pathfinder Asset Management.
The company intends to use the funds for the completion of their current clinical study at Princess Margaret Cancer Centre as well as product development and FDA regulatory clearance for their first tissue imaging product.
Led by Paul Weber, President and CEO, Perimeter is advancing the Optical Tissue Imaging System (OTIS™), an intraoperative medical imaging tool that provides clinicians with the ability to visualize the entire perimeter of excised tissue during surgery. The OTIS™ system is a platform technology that can be used to image many different tissue types, allowing surgeons to make better real time decisions during surgical procedures.